Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bastien Jamet

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Clinics and Research in Hepatology and Gastroenterology|January 19, 2025
Mixed neuroendocrine non-neuroendocrine neoplasm combining neuroendocrine tumor with hepatocellular carcinoma in the context of multiple endocrine neoplasia type 1Madeleine Mulsant, Jean-François Mosnier, Eric Frampas, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Case Report of Concomitant Diagnosis of Locally Advanced Intrahepatic Cholangiocarcinoma and Solitary Plasmacytoma of T11 Vertebra: Impact on Diagnostic and Clinical ManagementYann Touchefeu, Matthieu Barbaud, Laura Prin-Felix, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2019
<sup>18</sup>F-FDG PET/CT in multiple myeloma: critical insights and future directionsClément Bailly, Thomas Carlier, Bastien Jamet, et al.
Scientific Reports|August 31, 2021
Specific features to differentiate Giant cell arteritis aortitis from aortic atheroma using FDG-PET/CTOlivier Espitia, Jérémy Schanus, Christian Agard, et al.
Leukemia & Lymphoma|May 3, 2018
Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patientsBastien Jamet, Clément Bailly, Thomas Carlier, et al.
International Journal of Computer Assisted Radiology and Surgery|July 1, 2019
Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosisLudivine Morvan, Thomas Carlier, Bastien Jamet, et al.
European Radiology|April 6, 2023
Hybrid simultaneous whole-body 2-[<sup>18</sup>F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value resultsBastien Jamet, Thomas Carlier, Clément Bailly, et al.
EJNMMI Research|March 13, 2026
Optimal acquisition time of [<sup>68</sup>Ga]Ga-PentixaFor PET/CT for initial staging of multiple myeloma: an ancillary study to the PentiMyelo protocolChloé François, Thomas Carlier, Cyrille Touzeau, et al.
Clinical Nuclear Medicine|April 7, 2026
Prognostic Value of Cranial Arteries Involvement on 18F-FDG PET/CT at Giant Cell Arteritis Diagnosis in a Multicenter CohortRachel Bardy, Estelle Detournay, Alexis F Guedon, et al.
Cancers|February 26, 2020
Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple MyelomaBastien Jamet, Clément Bailly, Thomas Carlier, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Clinics and Research in Hepatology and Gastroenterology|January 19, 2025
Mixed neuroendocrine non-neuroendocrine neoplasm combining neuroendocrine tumor with hepatocellular carcinoma in the context of multiple endocrine neoplasia type 1Madeleine Mulsant, Jean-François Mosnier, Eric Frampas, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Case Report of Concomitant Diagnosis of Locally Advanced Intrahepatic Cholangiocarcinoma and Solitary Plasmacytoma of T11 Vertebra: Impact on Diagnostic and Clinical ManagementYann Touchefeu, Matthieu Barbaud, Laura Prin-Felix, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2019
<sup>18</sup>F-FDG PET/CT in multiple myeloma: critical insights and future directionsClément Bailly, Thomas Carlier, Bastien Jamet, et al.
Scientific Reports|August 31, 2021
Specific features to differentiate Giant cell arteritis aortitis from aortic atheroma using FDG-PET/CTOlivier Espitia, Jérémy Schanus, Christian Agard, et al.
Leukemia & Lymphoma|May 3, 2018
Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patientsBastien Jamet, Clément Bailly, Thomas Carlier, et al.
International Journal of Computer Assisted Radiology and Surgery|July 1, 2019
Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosisLudivine Morvan, Thomas Carlier, Bastien Jamet, et al.
European Radiology|April 6, 2023
Hybrid simultaneous whole-body 2-[<sup>18</sup>F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value resultsBastien Jamet, Thomas Carlier, Clément Bailly, et al.
EJNMMI Research|March 13, 2026
Optimal acquisition time of [<sup>68</sup>Ga]Ga-PentixaFor PET/CT for initial staging of multiple myeloma: an ancillary study to the PentiMyelo protocolChloé François, Thomas Carlier, Cyrille Touzeau, et al.
Clinical Nuclear Medicine|April 7, 2026
Prognostic Value of Cranial Arteries Involvement on 18F-FDG PET/CT at Giant Cell Arteritis Diagnosis in a Multicenter CohortRachel Bardy, Estelle Detournay, Alexis F Guedon, et al.
Cancers|February 26, 2020
Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple MyelomaBastien Jamet, Clément Bailly, Thomas Carlier, et al.
Pageof 5